Similarly, Sun and colleagues reported that the mesenchymal marker Vimentin was consistently overexpressed in hepatocellular carcinomas (HCCs) compared with cirrhotic and normal liver tissues, reinforcing the association between EMT and cancer progression [98]. This evidence concerns the gene VIM and hepatocellular carcinoma.